Novartis wins FDA breakthrough status for Sjögren's disease therapy
Source: SeekingAlpha
2026-01-16 12:28:20 ET
More on Novartis
- Novartis AG (NVS) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
- Novartis AG (NVS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Novartis: A Mispriced Hedge In A Crowded Equity Market
- Bristol Myers, Merck, Amgen among latest to announce U.S. drug pricing deal
- More pharmas expected to sign drug pricing deals with Trump on Friday - report
Read the full article on Seeking Alpha
For further details see:
Novartis wins FDA breakthrough status for Sjögren’s disease therapy
Novartis AG
NASDAQ: NVS
NVS Trading
-3.34% G/L:
$145.44 Last:
1,184,779 Volume:
$146.92 Open:
NVS Latest News
February 24, 2026 04:52:00 pm
Could Novartis Stock Quietly Help You Build a Millionaire Retirement Portfolio?
NVS Stock Data
$303,205,301,793
1,889,070,162
N/A
868
N/A
Pharmaceuticals
Healthcare
CH
Basel
